Companies / Adcendo
Adcendo
Denmark
Adcendo is developing a new generation of antibody-drug conjugates to address cancers with high unmet medical need.
Adcendo, based in Denmark, has 1 investor on file, among them Ysios Capital.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Ysios Capital
30 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (93%), Media & Entertainment (3%), Developer Tools (3%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Adcendo and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Ysios Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/adcendo.dk/investors
# also
GET /v1/companies/adcendo.dk
GET /v1/companies/adcendo.dk/news